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Background: Prior studies have suggested that thrombus aspiration prior to coronary stenting in patients with STEMI undergoing primary PCI 
(PPCI) improves clinical outcome.
Aim: To assess the impact of thrombus aspiration (TA) before stent implantation in STEMI pts undergoing PPCI on: (a) Infarct size: assessed by 
maximal CPK/troponin levels and LVEF; (b) MACE at 30 days (death, recurrent MI/ischemia, stent thrombosis, urgent revascularization, ischemic 
stroke).
Methods: 517 STEMI patients who underwent PPCI and hospitalized in 26 CCUs during a 2-month national ACS Israeli Survey (ACSIS) 2010 were 
included.
Results: 
PPCI with TA
(n=217)
PPCI without TA (n=300) P
Mean age (yrs, mean±SD) 60.7±11.8 61.2±11.8 0.21
Women (%) 20 17 0.34
Diabetes (%) 25 32 0.11
Killip II-IV (%) 13 8 0.05
LAD Culprit lesion (%) 48 46 0.59
Culprit lesion ostial-proximal vessel (%) 47 42 0.61
Time from symptom onset to reperfusion (min; median,Q1,Q3) 195 (130,317) 188 (131,330) 0.78
TIMI 0-1 before PPCI (%) 80 56 <0.0001
TIMI flow 3, end of PPCI (%) 90 92 0.38
Myocardial blush 3, end of PCI (%) 60 64 0.35
Stent diameter (mm; mean±SD) 3.19±0.66 3.02±0.53 0.002
Max- CPK (IU/L; median,Q1,Q3) 717 (410,1287) 690 (236,1300) 0.12
Max-Troponin-I (ng/ml; median,Q1,Q3) 22 (7,44) 12 (2,46) 0.01
LVEF > 40 (%) 69 74 0.35
30-day mortality (%) 3.2 3.7 0.77
30-day MACE (%) 10.6 9.7 0.73
On multivariate regression analysis only TIMI 0-1 before PPCI was independently associate with use of TA (OR=3.47;2.28-5.28, p<0.0001). Use of TA 
was not associated with a better 30-day MACE (OR=0.93;0.48-1.81, p=0.84) after covariate adjustment for pertinent variables and the propensity 
score for TA use.
Conclusions: In “real-world” practice use of thrombus aspiration before stent implantation in STEMI pts undergoing PPCI was not associated with 
a better outcome at 30 days, and did not affect infarct size.
